Eli Lilly’s Ebglyss (lebrikizumab) has been approved by the US FDA as a maintenance dose for patients with moderate-to-severe ...

As GLP-1s redefine the treatment landscape for obesity, they are also promising candidates to influence a wide range of ...

Discover why translation alone is not enough in global clinical trials and how expert localisation improves participant ...

CSL has been given marketing authorisation from the European Commission for Privigen, a human immunoglobulin therapy ...

GSK has agreed to acquire Nuvalent for $10.6bn. Nuvalent is a US-based, clinical-stage biopharmaceutical company focused on ...

The companies will co-develop and co-commercialise bexobrutideg across malignant haematology, immunology and neurology ...

Regulatory changes and tariffs have created a positive climate for investment, innovation and, critically, patient access to ...

Alnylam Pharmaceuticals and Inceptive Nucleics, a company that builds foundation models of life, have announced a strategic ...

Biogen has announced that salanersen has been given the US FDA Breakthrough Therapy Designation to treat spinal muscular ...

Until the gap between what healthcare systems can offer and how men actually engage with them is closed, outcomes will ...

Pfizer and Innovent will co-develop four programmes globally and share the development costs. The companies will ...

Across sessions, panels, and conversations on the ground in Denver, there was a noticeable shift in both mindset and momentum ...